Synucure Therapeutics

Montreal, Canada

Synucure Therapeutics is a Canadian biotechnology business that operates research on degenerative brain illnesses.

$2.8M raised

Apr 2025

Seed

Biotechnology Health Care

Top Investors

Investissement Quebec

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Synucure Therapeutics

How much funding has Synucure Therapeutics raised?

Synucure Therapeutics has raised $2.8M in total funding. The most recent round was Seed. The last funding was announced in April 2025.

Who are Synucure Therapeutics's investors?

Synucure Therapeutics's investors include Investissement Quebec.

Where is Synucure Therapeutics headquartered?

Synucure Therapeutics is headquartered in Montreal, Canada.

What does Synucure Therapeutics do?

Synucure Therapeutics is a Canadian biotechnology business that operates research on degenerative brain illnesses.

What stage is Synucure Therapeutics at?

Synucure Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 7, 2025.

MLA

"Synucure Therapeutics — Funding & Investors." VCBacked, April 7, 2025, https://www.vcbacked.co/company/synucure-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2025). Synucure Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/synucure-therapeutics

Wikipedia (cite web)

{{cite web |title=Synucure Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/synucure-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 7, 2025.